Ok well my reasoning wasn’t particularly sophisticated, but I...

Ok well my reasoning wasn’t particularly sophisticated, but I would have thought it would be fairly obvious that the share price would drop.

For what it’s worth I’ve followed this for 5 years.

No recent announcement has had a direct material benefit on revenue
Validation of Akida is meaningless
Classic P&D graph with small buyers (mums and dads) buying small parcels.
Execs not buying on market
Zero revenue ever
A long way away from commercialisation and revenue
Phase 1 trials only with VORAGO
Mere collaborations, no binding agreements to guarantee income

I’d agree that we’re seeing some support in mid thirties in terms of P&D graph, but now this thing will start to fade in coming weeks to months.

Of course if there’s material news then great things will happen but the chances are exceedingly slim (even tho the product is good). Likely overtaken by big fish.

And LDN suggested revenue in 2021 (its always ‘next year’ with this guy)..... and never delivers anyway...

Cue the hate and bitterness but I didn’t buy into this nonsense and I haven’t watched the stock price reduce by a third in a few weeks.

WB (#157)